Pharmaceutical Policy
Documents
Eur_ Ctr_ Disease Prevention and Control et al_ (2024)
0 comments
Analysis in progress
Top issues in comments
Fabio Kaczala and Shlomo E_ Blum (2016)
0 comments
Analysis in progress
Top issues in comments
Fangzhou Wu et al_ (2019)
0 comments
Analysis in progress
Top issues in comments
FDA (1972)
0 comments
Analysis in progress
Top issues in comments
Frank M_ Aarestrup (2015)
0 comments
Analysis in progress
Top issues in comments
Frank M_ Aarestrup and Henrik C_ Wegener (1999)
0 comments
Analysis in progress
Top issues in comments
G_ Gellin et al_ (1989)
0 comments
Analysis in progress
Top issues in comments
G_L_ French (2005)
0 comments
Analysis in progress
Top issues in comments
Gang Liu et al_ (2022)
0 comments
Analysis in progress
Top issues in comments
GBD 2021 Antimicrobial Resistance Collaborators (2024)
0 comments
Analysis in progress
Top issues in comments
Gerard D_ Wright and Hendrik Poinar (2012)
0 comments
Analysis in progress
Top issues in comments
Getahun E_ Agga et al_ (2019)
0 comments
Analysis in progress
Top issues in comments